(A, C, E, G, I) Disease-free survival and (B, D, F, H, J) overall survival. For each ErbB-2 category shown, patients are subdivided by cyclophosphamide, doxorubicin, and fluorouracil dose. (A, B) ErB-2 = 0%; (C, D) ErB-2-low/P-ErB-2-negative; (E, F) ErB-2-low/P-ErB-2-positive; (G, H) Erb-2-high/P-ErB-2-negative; (I, J) ErB-2-high/P-ErB-2-positive.